Crossmark

The Comprehensive Management of Cerebellar Ataxia in Adults

Crossref DOI link: https://doi.org/10.1007/s11940-019-0549-2

Published Online: 2019-02-21

Published Print: 2019-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Stephen, Christopher D.

Brizzi, Kate T.

Bouffard, Marc A.

Gomery, Pablo

Sullivan, Stacey L.

Mello, Julie

MacLean, Julie

Schmahmann, Jeremy D.
License Information

Text and Data Mining valid from 2019-02-21
More Information

Article History

First Online: 21 February 2019

Compliance with Ethical Standards

:

: Kate Brizzi, Marc Bouffard, Pablo Gomery, Stacey Sullivan, Julie Mello, and Julie MacLean declare no potential conflicts of interest. Jeremy Schmahmann reports personal fees from Bayer, personal fees from Biogen, personal fees from Biohaven, personal fees from Cadent, personal fees from Pfizer, outside the submitted work; in addition, Dr. Schmahmann has a Brief Ataxia Rating Scale licensed to Schmahmann and the General Hospital Corporation, a Cerebellar Neuropsychiatric Rating Scale pending to Schmahmann and the General Hospital Corporation, and a Cerebellar Cognitive Affective syndrome/Schmahmann Scale pending to Schmahmann and the General Hospital Corporation, and Royalties from Elsevier, MacKeith, Oxford, Springer; Grants from National Ataxia Foundation, Ataxia-Telangiectasia Children’s Project, MINDlink Foundation. Christopher D. Stephen has been paid for work as an investigator as part of a multi-center US trial of troriluzole in the ataxias.

: This article does not contain any studies with human or animal subjects performed by any of the authors.